Oct. 1 Company Quick Takes: NVS, Microsoft to use AI for drug R&D; plus AstraZeneca, Tmunity-CHOP and AGTC-Otonomy deals

Novartis, Microsoft partner on AI for drug R&D
Novartis AG (NYSE:NVS; SIX:NOVN) is partnering with Microsoft Corp. (NASDAQ:MSFT) to use artificial intelligence for

Read the full 222 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE